Current Health
Provider of a remote patient monitoring and care-at-home platform that combines continuous wearable physiologic monitoring, telehealth, 24/7 clinical oversight, AI-driven deterioration detection, and program implementation services to support hospital-at-home, outpatient advanced therapies, clinical trials, and large-scale virtual care programs.
Industries
Nr. of Employees
medium (51-250)
Current Health
Patents
Products
Integrated assessments for therapy toxicity monitoring
Remote, standardized assessments for therapy-related toxicities with automated scoring, handwriting capture, and integrated video to support outpatient advanced therapy delivery.
Integrated assessments for therapy toxicity monitoring
Remote, standardized assessments for therapy-related toxicities with automated scoring, handwriting capture, and integrated video to support outpatient advanced therapy delivery.
Services
Provision of wearable monitoring kits, patient connectivity, 24/7 clinical command center monitoring, escalation pathways, and technical support for home-based acute and high-acuity care.
Provision of wearable monitoring kits, patient connectivity, 24/7 clinical command center monitoring, escalation pathways, and technical support for home-based acute and high-acuity care.
Expertise Areas
- Remote patient monitoring
- Hospital-at-home and virtual wards
- Outpatient advanced therapy delivery (CAR-T and bispecifics)
- Pharmacovigilance and real-world evidence generation
Key Technologies
- Wearable physiological sensors
- Continuous vital-sign monitoring
- AI / machine learning for deterioration detection
- Cloud-based clinical dashboards and analytics
News & Updates
Participation in an FDA innovation challenge focused on home-based detection and management of cytokine release syndrome (CRS).
Announcement of selection for an FDA innovation challenge addressing home-based CRS solutions.
Case study and operational insights on migrating advanced therapies to outpatient settings.
Series A funding announcement for AI-driven remote monitoring capabilities.
Company report describing rapid revenue growth and customer expansion in 2020.
Reported 54 peer-reviewed publications and abstracts (since 2023).
Participation in an FDA innovation challenge focused on home-based detection and management of cytokine release syndrome (CRS).
Announcement of selection for an FDA innovation challenge addressing home-based CRS solutions.
Case study and operational insights on migrating advanced therapies to outpatient settings.
Series A funding announcement for AI-driven remote monitoring capabilities.
Company report describing rapid revenue growth and customer expansion in 2020.
Reported 54 peer-reviewed publications and abstracts (since 2023).